Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia

McCubrey, James A.2022-01-312022-01-312015-03-021949-2553http://hdl.handle.net/10342/9587en-UST-acute lymphoblastic leukemiaPerifosinesmall molecules inhibitors (SMI)Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic LeukemiaArticle10.18632/oncotarget.3260